XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenues:        
Total revenues $ 1,405,000 $ 281,000 $ 2,234,000 $ 590,000
Operating expenses:        
Research and development 1,131,000 1,993,000 2,290,000 4,237,000
Change in fair value of contingent consideration     (140,000)  
Write-down of fixed assets 210,000   210,000  
Selling, general and administrative 6,370,000 3,674,000 10,439,000 7,397,000
Total operating expenses 9,088,000 7,157,000 15,243,000 13,256,000
Loss from operations (7,682,000) (6,876,000) (13,009,000) (12,666,000)
Interest expense (1,000) (6,000) (8,000) (9,000)
Other income, net 2,759,000 10,000 10,222,000 82,000
Change in fair value of common stock warrant liabilities (498,000) (3,079,000) (176,000) 5,082,000
Gain on extinguishment of warrant liability   47,000   47,000
Issuance and offering costs     (769,000)  
Net loss before income taxes (5,422,000) (9,904,000) (3,740,000) (7,464,000)
Income tax benefit (provision)   10,000   (7,000)
Net loss (5,422,000) (9,894,000) (3,740,000) (7,471,000)
Net loss attributable to non-controlling interest (161,000) (205,000) (538,000) (307,000)
Net loss attributable to common stockholders $ (5,261,000) $ (9,689,000) $ (3,202,000) $ (7,164,000)
Net loss per share attributable to common stockholders:        
Basic and diluted $ (0.24) $ (1.04) $ (0.15) $ (0.80)
Weighted-average number of shares used in per share calculations:        
Basic and diluted 21,745,403 9,327,317 21,271,960 8,989,265
Other comprehensive loss, net of tax        
Unrealized losses on investment securities       $ (1,000)
Foreign currency translation adjustment $ (12,000)   $ (12,000)  
Other comprehensive loss (12,000)   (12,000) (1,000)
Comprehensive loss attributable to common stockholders (5,273,000) $ (9,689,000) (3,214,000) (7,165,000)
Product        
Revenues:        
Total revenues 1,379,000 231,000 2,183,000 385,000
Operating expenses:        
Cost of product revenues 1,587,000 1,490,000 2,443,000 1,622,000
License        
Revenues:        
Total revenues       100,000
Royalty        
Revenues:        
Total revenues $ 26,000 12,000 $ 51,000 42,000
Contract Research And Government Grants        
Revenues:        
Total revenues   $ 38,000   $ 63,000